Back to Job Search
Expired
  • Location: London
  • Salary: £50000 - £60000 per annum, Benefits: bonus, health insurance, life insurance, pension and 25 days holiday
  • Job Type:Permanent

Posted about 1 month ago

  • Sector: Translational Science
  • Contact: James Hume
  • Contact Email: james.hume@nextphaserecruitment.com
  • Contact Phone: 01403 216216
  • Start Date: 2021-09-15
  • Job Ref: V-47015
A pioneering Biotech whose ambitions are to deliver innovative & life changing therapies to patients for a range of autoimmune and inflammatory diseases.  They have a unique T -cell based technology that they are harnessing to develop the next generation of therapies that are now progressing towards the clinic and have an expanding pipeline. 

They are seeking a Senior Scientist who will be a key part in the development of their therapies and their transition from Discovery to Clinical Trials and GMP Manufacture. This is an influential role with the responsibility for leading a small team and the development of manufacturing processes for their next generation of life changing products. 

The core responsibilities are:

  • Provide leadership, technical expertise and practical approaches to the Process Development Team
  • Design, conduct, optimise and evaluate new processes for manufacture in a  GMP environment.
  • Improve the existing process design focusing on efficiency and quality
  • Supervise and mentor more junior members of staff.
  • Manage multiple, complex multi-party projects at a time.
  • Manage and support external collaborators as a subject matter expert.
Key Required Expertise:

  • Prior experience of Process Development within a Cell or Gene Therapy or Relatable environment.
  • Expertise in cell based techniques including flow cytometry.
  • Experience of developing automated or closed systems or using equipment such as prodigy.
  • Expertise in Immunology and cell therapies.
  • Minimum BSc and relevant experience within process development.
  • Experience of leading / supervising a small team.
Company Overview:

The company have developed unique T – Cell technologies that are innovative and life changing for patients that suffer from autoimmune and inflammatory diseases.  As well as having the potential to prevent the rejection of new organs following transplant.  This technology is based on modular, engineered Tregs. 
They are engineering T – Cells ex vivo that suppress the immune system and have the ability to direct the cells to the right area of the body.  They are now expanding their operations as their cell therapies progress to clinical trials, develop their pipeline further and develop manufacturing operations for Phase I trials. 
As a company they are led by some of the leading minds in their field are driven and committed to the development of therapies that are life changing to patients.  With the vision to develop a global biopharmaceutical company that is bringing cell therapies for a range of diseases beyond their current pipeline.